{"protocolSection":{"identificationModule":{"nctId":"NCT02817087","orgStudyIdInfo":{"id":"Pro00014213"},"organization":{"fullName":"The Methodist Hospital Research Institute","class":"OTHER"},"briefTitle":"Multifocal Brain Magnetic Stimulation in Chronic Ischemic Stroke","officialTitle":"An Innovative Approach to Restoration of Function in Chronic Ischemic Stroke Using a New Wearable Multifocal Brain Stimulator"},"statusModule":{"statusVerifiedDate":"2020-09","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2016-05-27","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2019-03-13","type":"ACTUAL"},"completionDateStruct":{"date":"2019-03-13","type":"ACTUAL"},"studyFirstSubmitDate":"2016-03-31","studyFirstSubmitQcDate":"2016-06-24","studyFirstPostDateStruct":{"date":"2016-06-29","type":"ESTIMATED"},"resultsFirstSubmitDate":"2020-03-17","resultsFirstSubmitQcDate":"2020-09-09","resultsFirstPostDateStruct":{"date":"2020-10-05","type":"ACTUAL"},"lastUpdateSubmitDate":"2020-09-09","lastUpdatePostDateStruct":{"date":"2020-10-05","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR_INVESTIGATOR","investigatorFullName":"David Chiu, MD","investigatorTitle":"Principal Investigator/Sponsor-Investigator","investigatorAffiliation":"The Methodist Hospital Research Institute"},"leadSponsor":{"name":"David Chiu, MD","class":"OTHER"},"collaborators":[{"name":"The Methodist Hospital Research Institute","class":"OTHER"},{"name":"Seraya Medical Systems, LLC","class":"UNKNOWN"}]},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":true,"isUnapprovedDevice":true,"isUsExport":false},"descriptionModule":{"briefSummary":"Transcranial magnetic stimulation for post-stroke upper-body motor deficits.","detailedDescription":"This study uses transcranial magnetic stimulation (magnetic pulses delivered through a specially designed cap worn on the head aimed at specific motor areas of the brain (brain areas responsible for the body's physical movements) to test whether upper-body motor function can be improved.\n\nThis is a double-blind study where half of participants will receive active transcranial stimulation and the other half of the participants will receive no transcranial magnetic stimulation; all participants will wear the cap. Participants and some members of the research team will not know who received active magnetic brain stimulation."},"conditionsModule":{"conditions":["Stroke"],"keywords":["Stroke","chronic ischemic stroke","cerebrovascular accident (CVA)","ischaemic stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","interventionModelDescription":"Active repetitive transcranial magnetic stimulation administered through cap worn by patient under healthcare provider.","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"TRIPLE","maskingDescription":"Double-blind, only the care provider is aware of active treatment assignment.","whoMasked":["PARTICIPANT","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":38,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"repetitive Transcranial Magnetic Stimulation -On","type":"ACTIVE_COMPARATOR","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap delivering magnetic stimulation to part of the brain.","interventionNames":["Device: repetitive Transcranial Magnetic Stimulation -On"]},{"label":"repetitive Transcranial Magnetic Stimulation -Off","type":"SHAM_COMPARATOR","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap that does NOT delivery any magnetic stimulation to the brain.","interventionNames":["Device: repetitive Transcranial Magnetic Stimulation -Off"]}],"interventions":[{"type":"DEVICE","name":"repetitive Transcranial Magnetic Stimulation -On","description":"Cap worn on the scalp will deliver active Repetitive Transcranial Magnetic Stimulation to specific parts of the brain","armGroupLabels":["repetitive Transcranial Magnetic Stimulation -On"],"otherNames":["transcranial magnetic stimulation (TMS)","Transcranial Rotating Permanent Magnet Stimulation (TRPMS)","repetitive Transcranial Magnetic Stimulation (rTMS)"]},{"type":"DEVICE","name":"repetitive Transcranial Magnetic Stimulation -Off","description":"Cap worn on the scalp will no delivery of the Repetitive Transcranial Magnetic Stimulation to any part of the, referred to as a sham or inactive study treatment.","armGroupLabels":["repetitive Transcranial Magnetic Stimulation -Off"],"otherNames":["sham treatment","Control Group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Changes in Brain Activation","description":"Change in number of active voxels in the cortical areas surrounding the lesion on functional MRI","timeFrame":"One business day before treatment begins, one business day after treatment ends, up to 5 weeks"}],"secondaryOutcomes":[{"measure":"Fugl-Meyer Motor Arm Score","description":"Change in arm motor function Total score range is 0-66 with the higher number representing a better outcome","timeFrame":"One business day before treatment begins, one business day after treatment ends up to 5 weeks"},{"measure":"ARAT (Action Research Arm Test)","description":"Change in arm and hand motor function Total score range is 0-57 with the higher number representing a better outcome","timeFrame":"One business day before treatment begins, one business day after treatment ends up to 5 weeks"},{"measure":"Hand Dynamometer","description":"Change in grip strength The higher the number represents better outcome","timeFrame":"One business day before treatment begins, one business day after treatment ends up to 5 weeks"},{"measure":"Pinch Dynamometer Score","description":"Change in pinch strength. The higher the number, the better the outcome.","timeFrame":"One business day before treatment begins, one business day after treatment ends up to 5 weeks"},{"measure":"TUG (Timed Up and Go Test)","description":"Change in gait velocity on Timed Up and Go Test. The lower the time recorded, the better the outcome.","timeFrame":"One business day before treatment begins, one business day after treatment ends up to 5 weeks"},{"measure":"National Institutes of Health Stroke Scale (NIHSS)","description":"Change in National Institutes of Health Stroke Scale (NIHSS) Total score range is 0-42 with the lower number representing a better outcome","timeFrame":"One business day before treatment begins, one business day after treatment ends up to 5 weeks"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients aged 18-80 years;\n* Clinical diagnosis of chronic ischemic stroke recovering for more than 3 months with unilateral motor deficits of arm and leg, or arm alone; --\n\nExclusion Criteria:\n\n* History of seizure;\n* Epileptogenic activity (indicative of increased risk of seizures) on EEG;\n* Any active unstable medical condition;\n* Pregnancy;\n* Schizophrenia, bipolar disorder, alcoholism, or substance abuse;\n* Medications which in the investigator's clinical judgment significantly lower the seizure threshold;\n* Presence of metal or electronic implants in the head (or any in the body that preclude MRI) , including pacemakers, defibrillators, aneurysm clips, neuro-stimulators, cochlear implants, metal in the eyes, etc.;\n* Any changes in medications prescribed for the treatment of stroke impairment within six weeks prior to inclusion in the study or at any time during the study.\n* Botulinum toxin use within two months prior to the screening visit or any planned use of botulinum toxin during the study\n* Changes in NIHSS and motor assessment scores between Visit 1 and Visit 2 indicating that the patient's impairment is not stable. The following cutoffs, based on research establishing Clinically Important Differences, will be used for this determination:\n* National Institutes of Health Stroke Scale: A change in total score of more than 2 points in either direction, or a change in the motor extremity score of more than 1 point in either direction.\n* Fugl-Meyer Assessment of Sensorimotor Impairment: A change of more than 5 points in either direction on the upper-extremity motor score for the affected arm.\n* Action Research Arm Test: A change of more than 5 points in either direction on the ARAT score for the affected arm.\n* Any condition that precludes a high quality brain MRI scan.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"David Chiu, MD","affiliation":"The Methodist Hospital Research Institute","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Houston Methodist Hospital","city":"Houston","state":"Texas","zip":"77030","country":"United States","geoPoint":{"lat":29.76328,"lon":-95.36327}}]},"referencesModule":{"references":[{"pmid":"23090951","type":"BACKGROUND","citation":"Rehme AK, Grefkes C. Cerebral network disorders after stroke: evidence from imaging-based connectivity analyses of active and resting brain states in humans. J Physiol. 2013 Jan 1;591(1):17-31. doi: 10.1113/jphysiol.2012.243469. Epub 2012 Oct 22."},{"pmid":"25206743","type":"BACKGROUND","citation":"Li W, Li Y, Zhu W, Chen X. Changes in brain functional network connectivity after stroke. Neural Regen Res. 2014 Jan 1;9(1):51-60. doi: 10.4103/1673-5374.125330."},{"pmid":"23506092","type":"BACKGROUND","citation":"Varsou O, Macleod MJ, Schwarzbauer C. Functional connectivity magnetic resonance imaging in stroke: an evidence-based clinical review. Int J Stroke. 2014 Feb;9(2):191-8. doi: 10.1111/ijs.12033. Epub 2013 Mar 19."},{"pmid":"19798637","type":"BACKGROUND","citation":"Ameli M, Grefkes C, Kemper F, Riegg FP, Rehme AK, Karbe H, Fink GR, Nowak DA. Differential effects of high-frequency repetitive transcranial magnetic stimulation over ipsilesional primary motor cortex in cortical and subcortical middle cerebral artery stroke. Ann Neurol. 2009 Sep;66(3):298-309. doi: 10.1002/ana.21725."},{"pmid":"20809058","type":"BACKGROUND","citation":"Chang WH, Kim YH, Bang OY, Kim ST, Park YH, Lee PK. Long-term effects of rTMS on motor recovery in patients after subacute stroke. J Rehabil Med. 2010 Sep;42(8):758-64. doi: 10.2340/16501977-0590."},{"pmid":"16675743","type":"BACKGROUND","citation":"Kim YH, You SH, Ko MH, Park JW, Lee KH, Jang SH, Yoo WK, Hallett M. Repetitive transcranial magnetic stimulation-induced corticomotor excitability and associated motor skill acquisition in chronic stroke. Stroke. 2006 Jun;37(6):1471-6. doi: 10.1161/01.STR.0000221233.55497.51. Epub 2006 May 4. Erratum In: Stroke. 2006 Nov;37(11):2861."},{"pmid":"19678808","type":"BACKGROUND","citation":"Khedr EM, Etraby AE, Hemeda M, Nasef AM, Razek AA. Long-term effect of repetitive transcranial magnetic stimulation on motor function recovery after acute ischemic stroke. Acta Neurol Scand. 2010 Jan;121(1):30-7. doi: 10.1111/j.1600-0404.2009.01195.x. Epub 2009 Aug 11."},{"pmid":"16890483","type":"BACKGROUND","citation":"Fitzgerald PB, Fountain S, Daskalakis ZJ. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clin Neurophysiol. 2006 Dec;117(12):2584-96. doi: 10.1016/j.clinph.2006.06.712. Epub 2006 Aug 4."},{"pmid":"16809569","type":"BACKGROUND","citation":"Fregni F, Boggio PS, Valle AC, Rocha RR, Duarte J, Ferreira MJ, Wagner T, Fecteau S, Rigonatti SP, Riberto M, Freedman SD, Pascual-Leone A. A sham-controlled trial of a 5-day course of repetitive transcranial magnetic stimulation of the unaffected hemisphere in stroke patients. Stroke. 2006 Aug;37(8):2115-22. doi: 10.1161/01.STR.0000231390.58967.6b. Epub 2006 Jun 29."},{"pmid":"18502315","type":"BACKGROUND","citation":"Mally J, Dinya E. Recovery of motor disability and spasticity in post-stroke after repetitive transcranial magnetic stimulation (rTMS). Brain Res Bull. 2008 Jul 1;76(4):388-95. doi: 10.1016/j.brainresbull.2007.11.019. Epub 2007 Dec 26."},{"pmid":"17079967","type":"BACKGROUND","citation":"Boggio PS, Alonso-Alonso M, Mansur CG, Rigonatti SP, Schlaug G, Pascual-Leone A, Fregni F. Hand function improvement with low-frequency repetitive transcranial magnetic stimulation of the unaffected hemisphere in a severe case of stroke. Am J Phys Med Rehabil. 2006 Nov;85(11):927-30. doi: 10.1097/01.phm.0000242635.88129.38."},{"pmid":"20005962","type":"BACKGROUND","citation":"Grefkes C, Nowak DA, Wang LE, Dafotakis M, Eickhoff SB, Fink GR. Modulating cortical connectivity in stroke patients by rTMS assessed with fMRI and dynamic causal modeling. Neuroimage. 2010 Mar;50(1):233-42. doi: 10.1016/j.neuroimage.2009.12.029. Epub 2009 Dec 18."},{"type":"BACKGROUND","citation":"Helekar, S.A., et al., Electromyographic motor-evoked potentials elicited by transcranial magnetic stimulation with rapidly moving permanent magnets mounted on a multisite stimulator cap, in 2013 Neuroscience Meeting Planner. 2013, Society for Neuroscience: San Diego, CA."},{"pmid":"10408769","type":"BACKGROUND","citation":"Ashburner J, Friston KJ. Nonlinear spatial normalization using basis functions. Hum Brain Mapp. 1999;7(4):254-66. doi: 10.1002/(SICI)1097-0193(1999)7:4&#x0003c;254::AID-HBM4&#x0003e;3.0.CO;2-G."},{"pmid":"11771995","type":"BACKGROUND","citation":"Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002 Jan;15(1):273-89. doi: 10.1006/nimg.2001.0978."},{"pmid":"20202481","type":"BACKGROUND","citation":"Bressler SL, Seth AK. Wiener-Granger causality: a well established methodology. Neuroimage. 2011 Sep 15;58(2):323-9. doi: 10.1016/j.neuroimage.2010.02.059. Epub 2010 Mar 2."},{"pmid":"24893321","type":"BACKGROUND","citation":"Matias FS, Gollo LL, Carelli PV, Bressler SL, Copelli M, Mirasso CR. Modeling positive Granger causality and negative phase lag between cortical areas. Neuroimage. 2014 Oct 1;99:411-8. doi: 10.1016/j.neuroimage.2014.05.063. Epub 2014 Jun 2."},{"pmid":"16099512","type":"BACKGROUND","citation":"Chen Y, Bressler SL, Ding M. Frequency decomposition of conditional Granger causality and application to multivariate neural field potential data. J Neurosci Methods. 2006 Jan 30;150(2):228-37. doi: 10.1016/j.jneumeth.2005.06.011. Epub 2005 Aug 15."},{"pmid":"8416078","type":"BACKGROUND","citation":"Blair RC, Karniski W. An alternative method for significance testing of waveform difference potentials. Psychophysiology. 1993 Sep;30(5):518-24. doi: 10.1111/j.1469-8986.1993.tb02075.x."},{"pmid":"2568739","type":"BACKGROUND","citation":"Chiavarini M, Morini G, Barocelli E, Bordi F, Plazzi PV, Vitali T, Impicciatore M. Influence of urea-equivalent groups in position 5 of 2-amino, 2-(1-aminoethylidenamino) and 2-guanidino thiazole derivatives on H2-receptor antagonist activity in gastric fistula cat. Agents Actions. 1989 Apr;27(1-2):192-4. doi: 10.1007/BF02222236."},{"pmid":"21693536","type":"BACKGROUND","citation":"Carlowe J. Investigation into home care of elderly people shows cases of \"serious neglect\". BMJ. 2011 Jun 21;342:d3904. doi: 10.1136/bmj.d3904. No abstract available."},{"type":"BACKGROUND","citation":"S. A. Helekar and H. U. Voss,"}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"resultsSection":{"participantFlowModule":{"recruitmentDetails":"38 patients were screened 7 were screen fails. 2 withdrawn. 14 treated-Active, 15 treated-placebo.","groups":[{"id":"FG000","title":"Repetitive Transcranial Magnetic Stimulation -On","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap delivering magnetic stimulation to part of the brain.\n\nrepetitive Transcranial Magnetic Stimulation -On: Cap worn on the scalp will deliver active Repetitive Transcranial Magnetic Stimulation to specific parts of the brain"},{"id":"FG001","title":"Repetitive Transcranial Magnetic Stimulation -Off","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap that does NOT delivery any magnetic stimulation to the brain.\n\nrepetitive Transcranial Magnetic Stimulation -Off: Cap worn on the scalp will no delivery of the Repetitive Transcranial Magnetic Stimulation to any part of the, referred to as a sham or inactive study treatment."}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"16"},{"groupId":"FG001","numSubjects":"15"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","comment":"1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns","numSubjects":"14"},{"groupId":"FG001","numSubjects":"15"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"0"}]}],"dropWithdraws":[{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"0"}]}]}]},"baselineCharacteristicsModule":{"populationDescription":"1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns","groups":[{"id":"BG000","title":"Repetitive Transcranial Magnetic Stimulation -On","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap delivering magnetic stimulation to part of the brain.\n\nrepetitive Transcranial Magnetic Stimulation -On: Cap worn on the scalp will deliver active Repetitive Transcranial Magnetic Stimulation to specific parts of the brain"},{"id":"BG001","title":"Repetitive Transcranial Magnetic Stimulation -Off","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap that does NOT delivery any magnetic stimulation to the brain.\n\nrepetitive Transcranial Magnetic Stimulation -Off: Cap worn on the scalp will no delivery of the Repetitive Transcranial Magnetic Stimulation to any part of the, referred to as a sham or inactive study treatment."},{"id":"BG002","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"31"}]}],"measures":[{"title":"Age, Categorical","populationDescription":"1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"29"}]}],"categories":[{"title":"<=18 years","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]},{"title":"Between 18 and 65 years","measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"13"}]},{"title":">=65 years","measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"16"}]}]}]},{"title":"Age, Continuous","populationDescription":"1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns","paramType":"MEAN","dispersionType":"FULL_RANGE","unitOfMeasure":"years","classes":[{"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"29"}]}],"categories":[{"measurements":[{"groupId":"BG000","value":"65.4","lowerLimit":"47","upperLimit":"78"},{"groupId":"BG001","value":"66.3","lowerLimit":"45","upperLimit":"80"},{"groupId":"BG002","value":"65.8","lowerLimit":"45","upperLimit":"80"}]}]}]},{"title":"Sex: Female, Male","populationDescription":"1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"29"}]}],"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"15"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"14"}]}]}]},{"title":"Ethnicity (NIH/OMB)","populationDescription":"pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"29"}]}],"categories":[{"title":"Hispanic or Latino","measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"3"}]},{"title":"Not Hispanic or Latino","measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"26"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]}]}]},{"title":"Race (NIH/OMB)","populationDescription":"pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"29"}]}],"categories":[{"title":"American Indian or Alaska Native","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]},{"title":"Asian","measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}]},{"title":"Native Hawaiian or Other Pacific Islander","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]},{"title":"Black or African American","measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"3"}]},{"title":"White","measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"25"}]},{"title":"More than one race","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]}]}]},{"title":"Region of Enrollment","populationDescription":"1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns","paramType":"NUMBER","unitOfMeasure":"participants","classes":[{"title":"United States","denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"29"}]}],"categories":[{"measurements":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"29"}]}]}]},{"title":"Fugl-Meyer motor arm score","description":"Scale range is 0-66 with higher score representing a better outcome.","populationDescription":"1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns","paramType":"MEDIAN","dispersionType":"INTER_QUARTILE_RANGE","unitOfMeasure":"score on a scale","classes":[{"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"29"}]}],"categories":[{"measurements":[{"groupId":"BG000","value":"43","lowerLimit":"16","upperLimit":"56"},{"groupId":"BG001","value":"25","lowerLimit":"15","upperLimit":"52"},{"groupId":"BG002","value":"37.0","lowerLimit":"15.75","upperLimit":"54.25"}]}]}]},{"title":"National Institutes of Health Stroke Scale (NIHSS)","description":"Total score is 0-42, with the lower score representing a better outcome","populationDescription":"1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns","paramType":"MEDIAN","dispersionType":"INTER_QUARTILE_RANGE","unitOfMeasure":"score on a scale","classes":[{"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"29"}]}],"categories":[{"measurements":[{"groupId":"BG000","value":"3","lowerLimit":"2","upperLimit":"6"},{"groupId":"BG001","value":"3","lowerLimit":"1","upperLimit":"5"},{"groupId":"BG002","value":"3.0","lowerLimit":"1.75","upperLimit":"5.0"}]}]}]},{"title":"Action Research Arm Test (ARAT)","description":"Total score is 0-57 with the higher score representing a better outcome","populationDescription":"1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns","paramType":"MEDIAN","dispersionType":"INTER_QUARTILE_RANGE","unitOfMeasure":"score on a scale","classes":[{"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"29"}]}],"categories":[{"measurements":[{"groupId":"BG000","value":"29","lowerLimit":"0","upperLimit":"57"},{"groupId":"BG001","value":"6","lowerLimit":"0","upperLimit":"53"},{"groupId":"BG002","value":"14.0","lowerLimit":"0.0","upperLimit":"56.0"}]}]}]},{"title":"Hand Grip Strength","populationDescription":"1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns","paramType":"MEDIAN","dispersionType":"INTER_QUARTILE_RANGE","unitOfMeasure":"Pounds","classes":[{"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"29"}]}],"categories":[{"measurements":[{"groupId":"BG000","value":"19.7","lowerLimit":"0","upperLimit":"44"},{"groupId":"BG001","value":"30.6","lowerLimit":"0","upperLimit":"54.4"},{"groupId":"BG002","value":"21.8","lowerLimit":"0.0","upperLimit":"46.48"}]}]}]},{"title":"Pinch Strength","populationDescription":"1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns","paramType":"MEDIAN","dispersionType":"INTER_QUARTILE_RANGE","unitOfMeasure":"Pounds","classes":[{"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"29"}]}],"categories":[{"measurements":[{"groupId":"BG000","value":"6.5","lowerLimit":"0","upperLimit":"10"},{"groupId":"BG001","value":"3.83","lowerLimit":"1","upperLimit":"9.67"},{"groupId":"BG002","value":"4.7","lowerLimit":"0.75","upperLimit":"9.78"}]}]}]},{"title":"Gait velocity on Timed Up and Go Test","populationDescription":"1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns","paramType":"MEDIAN","dispersionType":"INTER_QUARTILE_RANGE","unitOfMeasure":"feet per second","classes":[{"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"29"}]}],"categories":[{"measurements":[{"groupId":"BG000","value":"1.32","lowerLimit":"0","upperLimit":"1.69"},{"groupId":"BG001","value":"1.45","lowerLimit":"0","upperLimit":"1.74"},{"groupId":"BG002","value":"1.45","lowerLimit":"0.0","upperLimit":"1.7"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Changes in Brain Activation","description":"Change in number of active voxels in the cortical areas surrounding the lesion on functional MRI","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","unitOfMeasure":"voxels","timeFrame":"One business day before treatment begins, one business day after treatment ends, up to 5 weeks","groups":[{"id":"OG000","title":"Repetitive Transcranial Magnetic Stimulation -On","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap delivering magnetic stimulation to part of the brain.\n\nrepetitive Transcranial Magnetic Stimulation -On: Cap worn on the scalp will deliver active Repetitive Transcranial Magnetic Stimulation to specific parts of the brain"},{"id":"OG001","title":"Repetitive Transcranial Magnetic Stimulation -Off","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap that does NOT delivery any magnetic stimulation to the brain.\n\nrepetitive Transcranial Magnetic Stimulation -Off: Cap worn on the scalp will no delivery of the Repetitive Transcranial Magnetic Stimulation to any part of the, referred to as a sham or inactive study treatment."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"15"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"48.5","lowerLimit":"-60","upperLimit":"81"},{"groupId":"OG001","value":"-30","lowerLimit":"-373.3","upperLimit":"0"}]}]}]},{"type":"SECONDARY","title":"Fugl-Meyer Motor Arm Score","description":"Change in arm motor function Total score range is 0-66 with the higher number representing a better outcome","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","unitOfMeasure":"score on a scale","timeFrame":"One business day before treatment begins, one business day after treatment ends up to 5 weeks","groups":[{"id":"OG000","title":"Repetitive Transcranial Magnetic Stimulation -On","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap delivering magnetic stimulation to part of the brain.\n\nrepetitive Transcranial Magnetic Stimulation -On: Cap worn on the scalp will deliver active Repetitive Transcranial Magnetic Stimulation to specific parts of the brain"},{"id":"OG001","title":"Repetitive Transcranial Magnetic Stimulation -Off","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap that does NOT delivery any magnetic stimulation to the brain.\n\nrepetitive Transcranial Magnetic Stimulation -Off: Cap worn on the scalp will no delivery of the Repetitive Transcranial Magnetic Stimulation to any part of the, referred to as a sham or inactive study treatment."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"15"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.5","lowerLimit":"0","upperLimit":"6.0"},{"groupId":"OG001","value":"2.0","lowerLimit":"-1.0","upperLimit":"8.0"}]}]}]},{"type":"SECONDARY","title":"ARAT (Action Research Arm Test)","description":"Change in arm and hand motor function Total score range is 0-57 with the higher number representing a better outcome","populationDescription":"Stroke patients greater than 3 months from qualifying stroke date","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","unitOfMeasure":"score on a scale","timeFrame":"One business day before treatment begins, one business day after treatment ends up to 5 weeks","groups":[{"id":"OG000","title":"Repetitive Transcranial Magnetic Stimulation -On","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap delivering magnetic stimulation to part of the brain.\n\nrepetitive Transcranial Magnetic Stimulation -On: Cap worn on the scalp will deliver active Repetitive Transcranial Magnetic Stimulation to specific parts of the brain"},{"id":"OG001","title":"Repetitive Transcranial Magnetic Stimulation -Off","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap that does NOT delivery any magnetic stimulation to the brain.\n\nrepetitive Transcranial Magnetic Stimulation -Off: Cap worn on the scalp will no delivery of the Repetitive Transcranial Magnetic Stimulation to any part of the, referred to as a sham or inactive study treatment."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"15"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0","upperLimit":"3.0"},{"groupId":"OG001","value":"0","lowerLimit":"0","upperLimit":"4.0"}]}]}]},{"type":"SECONDARY","title":"Hand Dynamometer","description":"Change in grip strength The higher the number represents better outcome","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","unitOfMeasure":"pounds","timeFrame":"One business day before treatment begins, one business day after treatment ends up to 5 weeks","groups":[{"id":"OG000","title":"Repetitive Transcranial Magnetic Stimulation -On","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap delivering magnetic stimulation to part of the brain.\n\nrepetitive Transcranial Magnetic Stimulation -On: Cap worn on the scalp will deliver active Repetitive Transcranial Magnetic Stimulation to specific parts of the brain"},{"id":"OG001","title":"Repetitive Transcranial Magnetic Stimulation -Off","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap that does NOT delivery any magnetic stimulation to the brain.\n\nrepetitive Transcranial Magnetic Stimulation -Off: Cap worn on the scalp will no delivery of the Repetitive Transcranial Magnetic Stimulation to any part of the, referred to as a sham or inactive study treatment."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"15"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.8","lowerLimit":"0","upperLimit":"4.9"},{"groupId":"OG001","value":"0","lowerLimit":"-2.2","upperLimit":"2.2"}]}]}]},{"type":"SECONDARY","title":"Pinch Dynamometer Score","description":"Change in pinch strength. The higher the number, the better the outcome.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","unitOfMeasure":"pounds","timeFrame":"One business day before treatment begins, one business day after treatment ends up to 5 weeks","groups":[{"id":"OG000","title":"Repetitive Transcranial Magnetic Stimulation -On","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap delivering magnetic stimulation to part of the brain.\n\nrepetitive Transcranial Magnetic Stimulation -On: Cap worn on the scalp will deliver active Repetitive Transcranial Magnetic Stimulation to specific parts of the brain"},{"id":"OG001","title":"Repetitive Transcranial Magnetic Stimulation -Off","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap that does NOT delivery any magnetic stimulation to the brain.\n\nrepetitive Transcranial Magnetic Stimulation -Off: Cap worn on the scalp will no delivery of the Repetitive Transcranial Magnetic Stimulation to any part of the, referred to as a sham or inactive study treatment."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"15"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":".17","lowerLimit":"0","upperLimit":".67"},{"groupId":"OG001","value":".33","lowerLimit":"0","upperLimit":".83"}]}]}]},{"type":"SECONDARY","title":"TUG (Timed Up and Go Test)","description":"Change in gait velocity on Timed Up and Go Test. The lower the time recorded, the better the outcome.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","unitOfMeasure":"feet per second","timeFrame":"One business day before treatment begins, one business day after treatment ends up to 5 weeks","groups":[{"id":"OG000","title":"Repetitive Transcranial Magnetic Stimulation -On","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap delivering magnetic stimulation to part of the brain.\n\nrepetitive Transcranial Magnetic Stimulation -On: Cap worn on the scalp will deliver active Repetitive Transcranial Magnetic Stimulation to specific parts of the brain"},{"id":"OG001","title":"Repetitive Transcranial Magnetic Stimulation -Off","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap that does NOT delivery any magnetic stimulation to the brain.\n\nrepetitive Transcranial Magnetic Stimulation -Off: Cap worn on the scalp will no delivery of the Repetitive Transcranial Magnetic Stimulation to any part of the, referred to as a sham or inactive study treatment."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"15"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":".04","lowerLimit":"0","upperLimit":".11"},{"groupId":"OG001","value":"0","lowerLimit":"-.11","upperLimit":".12"}]}]}]},{"type":"SECONDARY","title":"National Institutes of Health Stroke Scale (NIHSS)","description":"Change in National Institutes of Health Stroke Scale (NIHSS) Total score range is 0-42 with the lower number representing a better outcome","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","unitOfMeasure":"score on a scale","timeFrame":"One business day before treatment begins, one business day after treatment ends up to 5 weeks","groups":[{"id":"OG000","title":"Repetitive Transcranial Magnetic Stimulation -On","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap delivering magnetic stimulation to part of the brain.\n\nrepetitive Transcranial Magnetic Stimulation -On: Cap worn on the scalp will deliver active Repetitive Transcranial Magnetic Stimulation to specific parts of the brain"},{"id":"OG001","title":"Repetitive Transcranial Magnetic Stimulation -Off","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap that does NOT delivery any magnetic stimulation to the brain.\n\nrepetitive Transcranial Magnetic Stimulation -Off: Cap worn on the scalp will no delivery of the Repetitive Transcranial Magnetic Stimulation to any part of the, referred to as a sham or inactive study treatment."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"15"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"-1","upperLimit":"0"},{"groupId":"OG001","value":"0","lowerLimit":"0","upperLimit":"0"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"0","timeFrame":"Adverse events were captured from time of first treatment to completion of the final visit at 3 months post treatment. Serious adverse events were captured from time of informed consent to completion of the final visit at 3 months post treatment.","description":"All reported events were assessed by the Principal Investigator and resulted in no withdrawals due to study treatment","eventGroups":[{"id":"EG000","title":"Repetitive Transcranial Magnetic Stimulation -On","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap delivering magnetic stimulation to part of the brain.\n\nrepetitive Transcranial Magnetic Stimulation -On: Cap worn on the scalp will deliver active Repetitive Transcranial Magnetic Stimulation to specific parts of the brain","deathsNumAffected":0,"deathsNumAtRisk":16,"seriousNumAffected":2,"seriousNumAtRisk":16,"otherNumAffected":1,"otherNumAtRisk":16},{"id":"EG001","title":"Repetitive Transcranial Magnetic Stimulation -Off","description":"Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap that does NOT delivery any magnetic stimulation to the brain.\n\nrepetitive Transcranial Magnetic Stimulation -Off: Cap worn on the scalp will no delivery of the Repetitive Transcranial Magnetic Stimulation to any part of the, referred to as a sham or inactive study treatment.","deathsNumAffected":0,"deathsNumAtRisk":15,"seriousNumAffected":2,"seriousNumAtRisk":15,"otherNumAffected":3,"otherNumAtRisk":15}],"seriousEvents":[{"term":"Acute Ischemic Stroke","organSystem":"Nervous system disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Relationship= Unlikely","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":16},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":15}]},{"term":"Urinary tract infection","organSystem":"Renal and urinary disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Relationship= Unlikely","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":16},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":15}]},{"term":"Migraine","organSystem":"Nervous system disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Relationship=Unlikely","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":16},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":15}]},{"term":"Renal stone","organSystem":"Renal and urinary disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":16},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":15}]},{"term":"Seizure","organSystem":"Nervous system disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"3 weeks post-treatment. Relationship=Unlikely","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":16},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":15}]}],"otherEvents":[{"term":"Fall","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":16},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":15}]},{"term":"Fatigue","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":16},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":15}]},{"term":"Muscle cramps","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":16},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":15}]},{"term":"Dizziness","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":16},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":15}]},{"term":"Transient tinnitus","organSystem":"Ear and labyrinth disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":16},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":15}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"pointOfContact":{"title":"David Chiu, M.D.","organization":"Houston Methodist Neurological Institute","email":"dmccane@houstonmethodist.org","phone":"713-441-5801"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot_SAP","hasProtocol":true,"hasSap":true,"hasIcf":false,"label":"Study Protocol and Statistical Analysis Plan","date":"2018-04-01","uploadDate":"2020-01-31T12:40","filename":"Prot_SAP_000.pdf","size":674508},{"typeAbbrev":"ICF","hasProtocol":false,"hasSap":false,"hasIcf":true,"label":"Informed Consent Form","date":"2018-05-08","uploadDate":"2020-09-09T16:35","filename":"ICF_001.pdf","size":575650}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T1303","name":"Chronic Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":true}